DIPA compounds as local reagents applied to treatment of sensory discomfort

A propylphosphonoheptane, topical technology for use in the field of therapeutic compounds

Inactive Publication Date: 2016-11-23
奥云达药业
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No biological activity of this diisop...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • DIPA compounds as local reagents applied to treatment of sensory discomfort
  • DIPA compounds as local reagents applied to treatment of sensory discomfort
  • DIPA compounds as local reagents applied to treatment of sensory discomfort

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

[0030] Embodiment 1: A therapeutic product comprising a compound of Formula 1 and a delivery vehicle carrying the compound of Formula 1 in said therapeutic product:

[0031]

[0032] Wherein, R is n-pentyl, n-hexyl, n-heptyl, and / or n-nonyl;

[0033] The delivery vehicle is suitable for topical delivery.

Embodiment approach 2

[0034] Embodiment 2: The therapeutic article of Embodiment 1, wherein the compound is 1-diisopropylphosphonopentane.

Embodiment approach 3

[0035] Embodiment 3: The therapeutic article of Embodiment 1, wherein the compound is 1-diisopropylphosphonohexane.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides DIPA compounds as local reagents applied to treatment of sensory discomfort and generally relates to the field of therapeutic compounds. More particularly, the invention relates to certain DIPA compounds collectively known as DIPA-1-5, DIPA-1-6, DIPA-1-7, DIPA-1-8 and DIPA-1-9 in the specification. The DIPA compounds can be applied to treatment of symptoms such as sensory discomfort, skin dysesthesia, dermatitis, eye pain and discomfort, heat discomfort, heat stress, blush and/or night sweat, postoperative hypothermia, postanesthesia shivering, fatigue, tiredness, depression and cognitive dysfunction, and can be used for enhancing the cognitive function.

Description

technical field [0001] The present invention relates generally to the field of therapeutic compounds. More specifically, the present invention relates to certain diisopropylphosphonoalkanes (DIPA-1-5, DIPA-1-6, DIPA-1-7, collectively referred to herein as "DIPA compounds") as described herein. , DIPA-1-8, and DIPA-1-9), these diisopropylphosphonoalkanes are useful, for example, in the treatment of disorders (e.g., diseases) that include: sensory discomfort (e.g., caused by irritation, itching, or pain ), skin dysesthesia, atopic dermatitis, ocular pain and discomfort, thermal malaise, heat stress, flushing and / or night sweats (vasomotor symptoms), postoperative hypothermia, postanesthesia rigors, fatigue, exhaustion, Depression, cognitive impairment, and may be used to enhance cognitive function. The invention also relates to pharmaceutical compositions comprising such compounds, and to the use of such compounds and compositions, for example in therapy, diagnosis, and labora...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/662A61K49/00A61P29/00A61P17/04A61P17/00A61P27/02A61P25/24A61P25/28A61P43/00
Inventor 魏德烽
Owner 奥云达药业
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap